New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - sacubitril/valsartan 200mg (as sodium hydrate complex, contains 97.2 mg sacubitril and 102.8 mg valsartan);  ;   - film coated tablet - 97.2 mg/102.8 mg - active: sacubitril/valsartan 200mg (as sodium hydrate complex, contains 97.2 mg sacubitril and 102.8 mg valsartan)     excipient: colloidal silicon dioxide crospovidone hyprolose basic coating mixture, white basic coating mixture, red basic coating mixture, black magnesium stearate microcrystalline cellulose purified talc purified water - entresto is indicated in adult patients with chronic heart failure (nyha class ii-iv). benefits are most clearly evident in patients with left ventricular ejection fraction (lvef) below normal. lvef is a variable measure, so use clinical judgment in deciding whom to treat

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) capsules (special order - magnesium glycerophosphate - oral capsule - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) tablets (special order - magnesium glycerophosphate - oral tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) oral powder sachets (special order - magnesium glycerophosphate - oral powder - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) chewable tablets (arjun products ltd - magnesium glycerophosphate - chewable tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) chewable tablets sugar free (special order - magnesium glycerophosphate - chewable tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) capsules (ennogen healthcare ltd - magnesium glycerophosphate - oral capsule - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) chewable tablets (ennogen healthcare ltd - magnesium glycerophosphate - chewable tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) tablets (ennogen healthcare ltd - magnesium glycerophosphate - oral tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97.2mg (4mmol)) chewable tablets (your products ltd - magnesium glycerophosphate - chewable tablet - 97.2mg